Super-Zymes
Natural health product licensed in Canada
- Licence holder
- Healthy Alternatives
- NPN or DIN-HM
- 80035663
- Status
- Active licence
- Licence date
- 28 September 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Protéase Source : Aspergillus niger | 15 FCC SAPU | Not calculated |
| Protéase Source : Aspergillus niger | 14.02 mg | Not calculated |
| 3-(1-3,1-4)-bêta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum | 4.29 mg | Not calculated |
| 3-(1-3,1-4)-bêta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum | 15 FCC BGU | Not calculated |
| Chlorella vulgaris Source : En entier | 13.3 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 8,500 FCC DU | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 56.67 mg | Not calculated |
| Beta-D-Fructofuranosidase Source : Saccharomyces cerevisiae | 35 mg | Not calculated |
| Bromélaïne de fruit Source : Ananas | 41.67 mg | Not calculated |
| Bromélaïne de fruit Source : Ananas comosus | 41.67 mg | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Aspergillus niger | 2.27 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 20 mg | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger | 15 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 10,000 FCC HUT | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae | 8.75 mg | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae | 175 FCC LU | Not calculated |
| alpha-L-arabinofuranoside arabinofuranohydrolase Source : Aspergillus niger | 1,138.1 FCC HCU | Not calculated |
| myo-Inositol-hexakisphosphate 3-phosphohydrolase Source : Aspergillus niger | 2.8 FCC FTU | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 4 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
To assist digestion.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80035663
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.